Geerke DP
ORCID: 0000-0002-5262-6166
· 1 paper in corpus
Cytochrome P450 aromatase (CYP19A1) plays a key role in the development of estrogen dependent breast cancer, and aromatase inhibitors have been at the front line of treatment for the past three decades. The development of potent, selective …